Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Physicians who Treat Diabetes (US)(?)

Council Members in this Study Group: 429

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Rohit Arora, MD
Professor of Medicine
Finch University of Health Science-Chicago Medical School

Rohit Arora, MD, FACC, FAHA, FASCI, FACP, is a Professor of Medicine and Professor of Physiology and Biophysics at Chicago Medical School, Illinois. He is also the Chairman of Cardiology and Associate Chairman of Medicine in the Department of Medicine. Dr. Arora is also Chief of Cardiology at the North...

Bruce Goldberg
President
Pharmacy Express Services, Inc.

Bruce Goldberg is the Founder and President of Pharmacy Express Services, Inc., a retail chain based in Nebraska. Mr. Goldberg is a pharmacist and has experience in managed care with PBM contracting and general pharmacy network management. He has developed a program which will allow generic and therapeutic...

Joseph Bass, MD, PhD, Division Head of Endocrinology and Metabolism, Evanston Northwestern HealthcareJoseph Bass, MD, PhD
Division Head of Endocrinology and Metabolism
Evanston Northwestern Healthcare

Joseph Bass, MD, PhD, is Assistant Professor of Medicine and Neurobiology at Northwestern University in Illinois and Division Head of Endocrinology and Metabolism at Evanston Northwestern Healthcare. He is also the Director of a federally-funded basic research program on obesity, diabetes, and lipid...

Harold Bays, MD, FACP, President and Medical Director, L-MARC Research CenterHarold Bays, MD, FACP
President and Medical Director
L-MARC Research Center

Harold Bays, MD, FACE, FACP, is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center (L-MARC), a metabolic clinical research facility that has conducted over 400 phase I-IV clinical trials, including studies of all marketed lipid-altering drug treatments, as well...

Dipti Doshi, MD
Rheumatologist
HEALTHCARE PARTNERS MEDICAL GROUP

Dipti Doshi, MD, is a board certified Rheumatologist at Health Care Partners Medical group, California. Dr. Doshi is also board certified in Internal Medicine. Her special interests are in rheumatoid arthritis, lupus, pain-related to scleroderma, fibromyalgia, and osteoarthritis. Dr. Doshi is interested...

Dan Streja, MD
Clinical Professor of Medicine
University of California, Los Angeles

Dan Streja, MD, is a Clinical Professor of Medicine at the University of California, Los Angeles. He is Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic and Diabetes Clinic, and the Divisions of Cardiology and Endocrinology at VA Medical Center of West Los Angeles. Dr. Streja has...

Kelly Close, President, Close ConcernsKelly Close
President
Close Concerns

Kelly Close is Founder and President of Close Concerns, a healthcare information firm focused exclusively on diabetes and obesity. She has over 15 years of experience at the intersection of finance and healthcare. Ms. Close specializes in financial analysis and marketing within the diabetes and obesity...

Carlos Dujovne, MD, Professor of Medicine and Director, OREGON HEALTH & SCIENCE UNIVERSITY - CCCarlos Dujovne, MD
Professor of Medicine and Director
OREGON HEALTH & SCIENCE UNIVERSITY - CC

Carlos Dujovne, MD, is an Internist, Gastroenterologist, Clinical Pharmacologist, Certified Clinical Lipidologist, Fr. Prof. of Medicine and Pharmacology, and Director of Clinical Pharmacology's Lipid-Arteriosclerosis Prevention-Treatment Clinic in Dept. of Medicine and Pharmacology at University of...

View all Leading Experts in this Study Group

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Designing effective medications for populations depends on how easy it is to diagnose the populations. | 12-01-2008
Analysis of: Personal medicine is goal of Eli Lilly & Co. | www.azcentral.com
Author: GLG Expert Contributor

The article indicates that medications will be designed to be effective for particular populations.  This will prevent the need to try medications which are effective for 50% of the population or less.

perspective on diabetes treatments | 11-24-2008
Analysis of: Are Costly Diabetes Pills Doing Any Good? | www.pharmalot.com
Author: GLG Expert Contributor

1. Yes, more expensive glucose-lowering drugs are being more widely used. 2. No, I do not think that medical evidence suggests that this is incorrect.

Crestor's results in the Jupiter Study likely to change medical-economic perspectives in statin choices. | 11-13-2008
Author: Carlos Dujovne, MD, Professor of Medicine and Director, OREGON HEALTH & SCIENCE UNIVERSITY - CC

1:Crestor is the most potent statin in the market,yet is 3d in sales behind Zocor and Lipitor.2:The efficacy supriority together with its capacity to lower CRP levels led to the highest rate of ASCVD prevention in the shortest period of time evr documented in statin trials.3:The trial in near 18,000...

C. difficile not linked to antibiotics will change how I order stool studies | 10-13-2008
Author: GLG Expert Contributor

C. difficile is only linked to antibiotic use about half the time.  In addition c. difficile can complicate IBS more that previously thought.  This may be why antibiotics that cover c. difficile have been useful in treating irritable bowel syndrome.  

Clinical Trials Go Unpublished | 10-06-2008
Analysis of: Many Trial Reports on FDA-Approved Drugs Go Unpublished | www.washingtonpost.com
Author: GLG Expert Contributor

The articles more often go unpublished if the study indicates that there is no benefit to new drugs over older drugs.

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Owner
  • Physician - Division Head
  • Partner
  • President
  • Director

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-03T13:45:45.387